Mar 14, 2019
- The world's first minimally invasive mitral valve repair device now approved to help difficult-to-treat heart failure patients with clinically significant secondary mitral regurgitation
- Approval is based on groundbreaking pivotal data from the COAPT™ Trial
- New indication significantly expands number of people with mitral regurgitation that can be treated with the MitraClip device